These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
590 related articles for article (PubMed ID: 26646104)
41. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5. Ye F; Tian L; Zhou Q; Feng D Gene; 2019 Dec; 721():144093. PubMed ID: 31473323 [TBL] [Abstract][Full Text] [Related]
42. MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma. Zhu M; Zhang C; Chen D; Chen S; Zheng H Biomed Pharmacother; 2019 Sep; 117():108998. PubMed ID: 31207579 [TBL] [Abstract][Full Text] [Related]
43. LncRNA KIFAP3-5:1 inhibits epithelial-mesenchymal transition of renal tubular cell through PRRX1 in diabetic nephropathy. Du L; Lu Y; Wang J; Zheng Y; Li H; Liu Y; Wu X; Zhou J; Wang L; He L; Shi J; Xu L; Li X; Lu Q; Yin X Cell Biol Toxicol; 2024 Jun; 40(1):47. PubMed ID: 38869718 [TBL] [Abstract][Full Text] [Related]
44. Etoposide-induced protein 2.4 ameliorates high glucose-induced epithelial-mesenchymal transition by activating adenosine monophosphate-activated protein kinase pathway in renal tubular cells. Li F; Guo D; Zhi S; Jia K; Wang Y; Zhang A; Pei Y; Hao J Int J Biochem Cell Biol; 2022 Jan; 142():106117. PubMed ID: 34801707 [TBL] [Abstract][Full Text] [Related]
45. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517 [TBL] [Abstract][Full Text] [Related]
46. Astilbin inhibits high glucose-induced autophagy and apoptosis through the PI3K/Akt pathway in human proximal tubular epithelial cells. Chen F; Sun Z; Zhu X; Ma Y Biomed Pharmacother; 2018 Oct; 106():1175-1181. PubMed ID: 30119185 [TBL] [Abstract][Full Text] [Related]
47. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy. Gao BH; Wu H; Wang X; Ji LL; Chen C Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183 [TBL] [Abstract][Full Text] [Related]
48. Knockdown of miR-214 Alleviates Renal Interstitial Fibrosis by Targeting the Regulation of the PTEN/PI3K/AKT Signalling Pathway. Hou D; Wu Q; Wang S; Pang S; Liang H; Lyu H; Zhou L; Wang Q; Hao L Oxid Med Cell Longev; 2022; 2022():7553928. PubMed ID: 36285295 [TBL] [Abstract][Full Text] [Related]
49. Icariin inhibits epithelial mesenchymal transition of renal tubular epithelial cells via regulating the miR-122-5p/FOXP2 axis in diabetic nephropathy rats. Zang L; Gao F; Huang A; Zhang Y; Luo Y; Chen L; Mao N J Pharmacol Sci; 2022 Feb; 148(2):204-213. PubMed ID: 35063135 [TBL] [Abstract][Full Text] [Related]
50. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice. Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805 [TBL] [Abstract][Full Text] [Related]
51. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy. Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587 [TBL] [Abstract][Full Text] [Related]
52. miR-98-5p Alleviated Epithelial-to-Mesenchymal Transition and Renal Fibrosis via Targeting Hmga2 in Diabetic Nephropathy. Zhu Y; Xu J; Liang W; Li J; Feng L; Zheng P; Ji T; Bai S Int J Endocrinol; 2019; 2019():4946181. PubMed ID: 31885559 [TBL] [Abstract][Full Text] [Related]
53. hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy. Bai S; Xiong X; Tang B; Ji T; Li X; Qu X; Li W Oxid Med Cell Longev; 2021; 2021():8814163. PubMed ID: 34257820 [TBL] [Abstract][Full Text] [Related]
54. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
55. Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy. Du L; Qian X; Li Y; Li XZ; He LL; Xu L; Liu YQ; Li CC; Ma P; Shu FL; Lu Q; Yin XX Acta Pharmacol Sin; 2021 Feb; 42(2):242-251. PubMed ID: 32555442 [TBL] [Abstract][Full Text] [Related]
56. MicroRNA 1228 Mediates the Viability of High Glucose-Cultured Renal Tubule Cells through Targeting Thrombospondin 2 and PI3K/AKT Signaling Pathway. Mo T; Fu Q; Hu X; Fu Y; Li J Kidney Blood Press Res; 2022; 47(1):1-12. PubMed ID: 34784607 [TBL] [Abstract][Full Text] [Related]
57. Lysophosphatidic Acid Promotes Epithelial-Mesenchymal Transition in Kidney Epithelial Cells via the LPAR1/MAPK-AKT/KLF5 Signaling Pathway in Diabetic Nephropathy. Lee GH; Cheon J; Kim D; Jun HS Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142408 [TBL] [Abstract][Full Text] [Related]
58. miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer. Mansoori B; Mohammadi A; Naghizadeh S; Gjerstorff M; Shanehbandi D; Shirjang S; Najafi S; Holmskov U; Khaze V; Duijf PHG; Baradaran B J Cell Physiol; 2020 Feb; 235(2):920-931. PubMed ID: 31241772 [TBL] [Abstract][Full Text] [Related]
59. The coordinated roles of miR-26a and miR-30c in regulating TGFβ1-induced epithelial-to-mesenchymal transition in diabetic nephropathy. Zheng Z; Guan M; Jia Y; Wang D; Pang R; Lv F; Xiao Z; Wang L; Zhang H; Xue Y Sci Rep; 2016 Nov; 6():37492. PubMed ID: 27874055 [TBL] [Abstract][Full Text] [Related]
60. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway. Li YM; Li XJ; Yang HL; Zhang YB; Li JC Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]